282 related articles for article (PubMed ID: 10986355)
1. TorsinA accumulation in Lewy bodies in sporadic Parkinson's disease.
Shashidharan P; Good PF; Hsu A; Perl DP; Brin MF; Olanow CW
Brain Res; 2000 Sep; 877(2):379-81. PubMed ID: 10986355
[TBL] [Abstract][Full Text] [Related]
2. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.
Irizarry MC; Growdon W; Gomez-Isla T; Newell K; George JM; Clayton DF; Hyman BT
J Neuropathol Exp Neurol; 1998 Apr; 57(4):334-7. PubMed ID: 9600226
[TBL] [Abstract][Full Text] [Related]
3. [The mechanism of Lewy body formation in Parkinson's disease].
Wakabayashi K; Takahashi H
Nihon Rinsho; 2000 Oct; 58(10):2022-7. PubMed ID: 11068441
[TBL] [Abstract][Full Text] [Related]
4. A close association of torsinA and alpha-synuclein in Lewy bodies: a fluorescence resonance energy transfer study.
Sharma N; Hewett J; Ozelius LJ; Ramesh V; McLean PJ; Breakefield XO; Hyman BT
Am J Pathol; 2001 Jul; 159(1):339-44. PubMed ID: 11438481
[TBL] [Abstract][Full Text] [Related]
5. Synphilin-1 and parkin show overlapping expression patterns in human brain and form aggresomes in response to proteasomal inhibition.
Bandopadhyay R; Kingsbury AE; Muqit MM; Harvey K; Reid AR; Kilford L; Engelender S; Schlossmacher MG; Wood NW; Latchman DS; Harvey RJ; Lees AJ
Neurobiol Dis; 2005 Nov; 20(2):401-11. PubMed ID: 15894486
[TBL] [Abstract][Full Text] [Related]
6. Proteomic approach to studying Parkinson's disease.
Zhang J; Goodlett DR
Mol Neurobiol; 2004 Jun; 29(3):271-88. PubMed ID: 15181239
[TBL] [Abstract][Full Text] [Related]
7. Lewy-body formation is an aggresome-related process: a hypothesis.
Olanow CW; Perl DP; DeMartino GN; McNaught KS
Lancet Neurol; 2004 Aug; 3(8):496-503. PubMed ID: 15261611
[TBL] [Abstract][Full Text] [Related]
8. Controversy: is Parkinson's disease a single disease entity? Yes.
Takahashi H; Wakabayashi K
Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S31-7. PubMed ID: 15885626
[TBL] [Abstract][Full Text] [Related]
9. TorsinA and heat shock proteins act as molecular chaperones: suppression of alpha-synuclein aggregation.
McLean PJ; Kawamata H; Shariff S; Hewett J; Sharma N; Ueda K; Breakefield XO; Hyman BT
J Neurochem; 2002 Nov; 83(4):846-54. PubMed ID: 12421356
[TBL] [Abstract][Full Text] [Related]
10. Synphilin-1 is present in Lewy bodies in Parkinson's disease.
Wakabayashi K; Engelender S; Yoshimoto M; Tsuji S; Ross CA; Takahashi H
Ann Neurol; 2000 Apr; 47(4):521-3. PubMed ID: 10762166
[TBL] [Abstract][Full Text] [Related]
11. Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease.
Mattila PM; Rinne JO; Helenius H; Dickson DW; Röyttä M
Acta Neuropathol; 2000 Sep; 100(3):285-90. PubMed ID: 10965798
[TBL] [Abstract][Full Text] [Related]
12. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
Hill WD; Arai M; Cohen JA; Trojanowski JQ
J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
[TBL] [Abstract][Full Text] [Related]
13. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
Kingsbury AE; Daniel SE; Sangha H; Eisen S; Lees AJ; Foster OJ
Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
[TBL] [Abstract][Full Text] [Related]
14. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208
[TBL] [Abstract][Full Text] [Related]
15. Failure of the ubiquitin-proteasome system in Parkinson's disease.
McNaught KS; Olanow CW; Halliwell B; Isacson O; Jenner P
Nat Rev Neurosci; 2001 Aug; 2(8):589-94. PubMed ID: 11484002
[No Abstract] [Full Text] [Related]
16. A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death.
Greffard S; Verny M; Bonnet AM; Seilhean D; Hauw JJ; Duyckaerts C
Neurobiol Aging; 2010 Jan; 31(1):99-103. PubMed ID: 18457903
[TBL] [Abstract][Full Text] [Related]
17. LRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodies.
Dzamko N; Gysbers AM; Bandopadhyay R; Bolliger MF; Uchino A; Zhao Y; Takao M; Wauters S; van de Berg WD; Takahashi-Fujigasaki J; Nichols RJ; Holton JL; Murayama S; Halliday GM
Mov Disord; 2017 Mar; 32(3):423-432. PubMed ID: 27911006
[TBL] [Abstract][Full Text] [Related]
18. [Lewy bodies in Parkinson's disease: histological, immunohistochemical, and interferometric examinations].
Voronkov DN; Salkov VN; Anufriev PL; Khudoerkov RM
Arkh Patol; 2018; 80(4):9-13. PubMed ID: 30059066
[TBL] [Abstract][Full Text] [Related]
19. [Alpha-synuclein interacted proteins: the relevance with the pathogenesis of Parkinson's disease].
Xu F; Luo JH; Jin JH
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 37(5):524-30. PubMed ID: 18925724
[TBL] [Abstract][Full Text] [Related]
20. Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease.
Mezey E; Dehejia AM; Harta G; Tresser N; Suchy SF; Nussbaum RL; Brownstein MJ; Polymeropoulos MH
Mol Psychiatry; 1998 Nov; 3(6):493-9. PubMed ID: 9857974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
